Dec 16 (Reuters) - Qlife Holding AB QLIFE.ST:
THE LETTER OF INTENT WITH HIPRO BIOTECHNOLOGY REGARDING THE REVERSE TAKEOVER HAS BEEN EXTENDED UNTIL 31 DECEMBER 2026 AND THE VALUATION TERM WILL RE-EVALUATED ONCE A STRUCTURE HAS BEEN ESTABLISHED
EXTENDS LETTER OF INTENT FOR REVERSE TAKEOVER WITH HIPRO
NASDAQ STOCKHOLM WILL NOT APPROVE 'RED CHIP' STRUCTURE
VALUATION TERM TO BE RE-EVALUATED AFTER REVISED STRUCTURE
Source text: ID:nWkr6lmrfh
Further company coverage: QLIFE.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))